{"gao_id": "GAO-23-105713", "published": "2023-02-02T12:00:00Z", "released": "2023-02-02T07:00:00Z", "summary": "In 2012, Health and Human Services (HHS) established a program to ensure the U.S. could rapidly produce medical countermeasures\u2014such as drugs and vaccines\u2014in public health emergencies. The program didn't meet its goals in responding to the COVID-19 pandemic, HHS found, and had trouble with large-scale production and quality control. HHS is transitioning to a new program but needs to take additional steps to ensure that...", "title": "Public Health Preparedness: HHS Should Plan for Medical Countermeasure Development and Manufacturing Risks", "topics": ["Government contracts", "Medical countermeasures", "Manufacturing", "Public health", "Health care", "Compliance oversight", "pandemics", "Health Care", "Vaccinations", "Public and private partnerships", "Public health emergencies"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-105713", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-23-105713-highlights.pdf"}, {"title": "Full Report (35 pages)", "url": "https://www.gao.gov/assets/gao-23-105713.pdf"}, {"title": "Accessible PDF (40 pages)", "url": "https://www.gao.gov/assets/820/817259.pdf"}]}